[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359736-105":59,"doc-detail-359736-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ilc2s-and-their-immune-checkpoints-in-the-antitumor-response","ILC2s and their immune checkpoints in the antitumor response","","Innate lymphoid cells (ILCs) are tissue-resident lymphocytes that patrol mucosal barriers. Among ILC subsets, ILC2s are well known for innate defense against parasites, roles in asthma development, and repair of damaged tissues. Their function in antitumor immunity remains controversial and appears to depend on cancer type and microenvironmental interactions. Recent studies examine immune checkpoint expression and function in ILC2s, focusing on PD-1 and CTLA-4.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ilc2s-and-their-immune-checkpoints-in-the-antitumor-response/359736/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ilc2s-and-their-immune-checkpoints-in-the-antitumor-response/359736.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is the antitumor role of ILC2s described as controversial?","Question",{"text":112,"@type":113},"Their involvement depends on tumor type and interactions with other immune and non-immune cells in the tumor microenvironment, making effects variable across contexts.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What immune checkpoints are highlighted in relation to ILC2s?",{"text":117,"@type":113},"Recent work focuses on programmed cell death protein-1 (PD-1) and cytotoxic T lymphocyte-associated protein-4 (CTLA-4) and how they may shape ILC2 function during cancer and immunotherapy.",{"name":119,"@type":110,"acceptedAnswer":120},"What effector functions do ILC2s have in tissue repair and parasite defense?",{"text":121,"@type":113},"ILC2s support mucosal repair by producing amphiregulin in response to IL-33, and they contribute to parasite expulsion by producing IL-4, IL-5, and IL-13 in response to IL-25.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359736,1790387243,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Open access  \nTo cite: Ciancaglini C, Santopolo S, Vacca P, et al.  \nILC2s and their immune checkpoints in the antitumor response. Journal for ImmunoTherapy of Cancer 2026;14:e014183 . doi:10 . 1136/ jitc-2025-014183  \nAccepted 13 April 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \n1Innate Lymphoid Cell Unit, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy  \n2Tumor Immunology Unit, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy  \nCorrespondence to  \nDr Linda Quatrini;  \n[linda.quatrini@opbg.net](linda.quatrini@opbg.net)  \nReview  \nILC2s and their immune checkpoints in the antitumor response  \nCecilia Ciancaglini  ,1 Silvia Santopolo  ,1 Paola Vacca,1 Lorenzo Moretta,2 Linda Quatrini  1  \nABSTRACT  \nInnate lymphoid cells (ILCs) are tissue-resident lymphocytes that patrol mucosal barriers. Among ILC subsets, ILC2s’ involvement in the innate immune response to parasites, in the development of asthma and in the repair of damaged tissues is well known. However, their role in antitumor immune response is controversial, as it seems to be dependent on the type of cancer and on interaction with the other cell types in the microenvironment. Immune checkpoint expression and function have been studied recently in ILC2s, with a focus on programmed cell death protein-1 (PD-1) and cytotoxic T lymphocyte-associated protein-4 (CTLA-4) . This review summarizes recent progress in understanding the ILC2s’contribution to cancer development and response to immunotherapy targeting inhibitory checkpoints.  \nINTRODUCTION  \nInnate lymphoid cells (ILCs) are a population of immune cells involved in innate host defense and are mostly resident at mucosal barriers. Among ILC subsets, ILC2s contribute mainly to the type 2 innate immune response to parasites in the lung and intestine, in the pathogenesis of allergic disease and have a crucial role in tissue homeostasis and repair.1–3  \nThe major transcription factor expressed by ILC2s in mice and humans is GATA3, which regulates ILC2 development from progenitors in a dose-dependent fashion.4 GATA 3 plays a critical role for the ILC2 activation and function, inducing interleukin (IL)-5 and IL-13 cytokine production, amphiregulin production and cytokine responsiveness, by upregulating IL-25 and IL-33 receptors expression.5  \nMouse and human ILC2s have conserved effector functions, but a different tissue distribution: they are the prominent ILC population in the mouse intestine, while they are primarily resident at the lung mucosal barrier and in the peripheral blood (PB) in humans, and populate the gut only upon inflammation. In mice, activated “inflammatory” ILC2scan migrate from the gut to the lung upon helminth infection.6 Similarly, in humans, PB  \nresting CD45RA+ ILC2s leave the circulation and enter the lungs on antigen challenge, undergoing conversion to inflammatory CD45RO+ ILC2s.7  \nA single-cell RNA sequencing analysis of CD127+ ILCs in PB and tissue samples from healthy donors (HDs) revealed subsetspecific and tissue-specific profiles of ILC2 .8 PB ILC2 showed a phenotype associated with recirculation and migration, and acquired a “lung-like” gene signature upon exposure to an inflammatory type 2 environment,8 confirming that ILC2 phenotype and functions are strictly regulated by tissue-derived signals.9  \nWhile the contribution of ILC2 to allergy is clear, their effect on cancer occurrence and development is controversial, because it depends on the tumor microenvironment (TME) and the therapy regimen. In this review, we summarize ILC2 effector functions and how they are regulated in physiological and pathological conditions. We also give an overview of the existing evidence on ILC2 crosstalk with tumor and immune cells, ILC2 expression of immune checkpoints and association with tumor progression and immunotherapy response.  \nILC2 EFFECTOR FUNCTIONS  \nILC2s have an important role in","cbCaiddAwLQ5SvQC","https://ap.wps.com/l/cbCaiddAwLQ5SvQC","pdf",2068250,11,"English","# Introduction\n## ILC2 biology and tissue distribution\n## ILC2 differentiation, activation, and effector programs\n# ILC2 Effector Functions\n## Tissue repair and epithelial growth factor signaling\n## Parasite expulsion and type 2 immune responses\n## Lung inflammation, asthma, and chronic airway disease\n# ILC2s in Antitumor Immunity (Review Scope)\n## Immune checkpoint expression and immunotherapy relevance","[{\"question\":\"Why is the antitumor role of ILC2s described as controversial?\",\"answer\":\"Their involvement depends on tumor type and interactions with other immune and non-immune cells in the tumor microenvironment, making effects variable across contexts.\"},{\"question\":\"What immune checkpoints are highlighted in relation to ILC2s?\",\"answer\":\"Recent work focuses on programmed cell death protein-1 (PD-1) and cytotoxic T lymphocyte-associated protein-4 (CTLA-4) and how they may shape ILC2 function during cancer and immunotherapy.\"},{\"question\":\"What effector functions do ILC2s have in tissue repair and parasite defense?\",\"answer\":\"ILC2s support mucosal repair by producing amphiregulin in response to IL-33, and they contribute to parasite expulsion by producing IL-4, IL-5, and IL-13 in response to IL-25.\"}]","ILC2s and their immune checkpoints in the antitumor response | PDF",1790137677,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a62ec4002a77d2763ef26c41751c34af.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e87a26a8d88ce7ab7f76d437c893648f.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b3b83103fc18a2d1cb7cb3690cf6025.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66d970d70a49037bd8901661e39befeb.webp",980,1306]